Biofarm Posts 20% Higher Net Profit and 17% Higher Sales in Jan-Sep

11.14.2022 By Eduard Ivanovici

Drug manufacturer Biofarm (BIO.RO) recorded a net profit of RON65.7 million in the first nine months of 2022, an increase of 20% on the previous year, according to ZF calculations based on data published on the Bucharest Stock Exchange.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

Keywords:
biofarm
, pharmaceuticals
, sales
, profit
, growth

Please fill all required fields!

Your comment was successfully added!

Comments will appear only after the moderation.